Scientists from the Faculty of Life Sciences & Medicine have been working to screen drugs that could have the potential to target the COVID-19 virus.
Led by Professor Mauro Giacca, the team has been using robotic technology in King’s School of Cardiovascular Medicine & Sciences to study the functionality of drugs.
When the pandemic started to strike, we reconverted our activity to search whether, among the already approved and available drugs, there are any that can block viral replication and can thus be rapidly re-purposed against COVID-19.